Online Programs

Sort by Expiration Date :

COVID-19 Frontline Initiative: Supporting Patient Journeys through Resources and Tools to Promote Positive Patient Outcomes in Care

COVID-19 FRONTLINE podcasts provide a comprehensive and up-to-date perspective on the ever-changing management and prevention of COVID-19. Each podcast focuses on different issues facing clinicians and patients, such as managing patients with COVID-19, addressing the care of special populations during the pandemic, and coping with the long road to recovery.

Release Date: May 28, 2021
Expiration Date: May 28, 2022

Learn More & View Event »

Seeing Clearer: Optimizing the Use of Vascular Endothelial Growth Factor Inhibitors in Age-related Macular Degeneration

This online activity targets healthcare gaps correlated with screening, multidisciplinary care and timely intervention in age-macular degeneration (AMD), which can impact vision-related quality of life.

  • By addressing these gaps, you can assess whether your approach to AMD management through screening, utilization of clinical trial data to guide appropriate treatment and multidisciplinary coordination for comprehensive AMD management – could be modified to help both strategize treatment design and close these gaps.
  • Expert discussion will guide you in identifying appropriate opportunities for early intervention, as well as assessing impact that AMD can have on vision-related quality of life.
  • You will also be immersed in dynamic whiteboard animations to memorably highlight key points related to how the inflammatory and vascular endothelial growth factor (VEGF) pathways lead to the development of AMD, as well as the fundoscopic retinal changes associated with each stage of AMD.

Release Date: May 28, 2021
Expiration Date: May 28, 2022

Learn More & View Event »

COVID-19 Frontline:
An Innovative View of Monoclonal Therapies and Vaccines for COVID-19: Educating Patients on the Mechanism of Action, Safety, and Efficacy of Emerging Agents
Vaccine Track

This program will explore the use of vaccines and monoclonal antibody therapies for the prevention and treatment of patients with COVID-19. Innovative virtual reality animations will delve into the mechanism of action of emerging vaccines and monoclonal antibodies, the rationale for early administration of monoclonal antibodies in recently infected and uninfected individuals, and compare active and passive immunity.

Release Date: June 2, 2021
Expiration Date: June 2, 2022

Learn More & View Event »

COVID-19 Frontline:
An Innovative View of Monoclonal Therapies and Vaccines for COVID-19: Educating Patients on the Mechanism of Action, Safety and Efficacy of Emerging Agents
Treatments Track

This program will explore the use of polyclonal and monoclonal antibody therapies for the treatment of patients with COVID-19. Innovative virtual reality animations will delve into the mechanism of action of antibody therapies, the impact of SARS-CoV-2 variants on treatment efficacy, and the role of dual monoclonal antibody cocktails in the prevention of viral escape.

Release Date: June 2, 2021
Expiration Date: June 2, 2022

Learn More & View Event »

Tackling COVID-19 and its Viral Variants on the Frontline with New Vaccines and Novel Monoclonal Antibody Treatments

This COVID-19 FRONTLINE Whiteboard Module will explore the role of emerging SARS-CoV-2 variants and their potential impact on the efficacy of current monoclonal antibody therapies and vaccines authorized for emergency use in managing the COVID-19 pandemic. We will focus on SARS-CoV-2 viral variants and emerging clinical data of their impact on vaccines and monoclonal antibodies currently authorized for emergency use. A whiteboard animation will be used to enhance the learning experience of this activity.

Release Date: June 2, 2021
Expiration Date: June 2, 2022

Learn More & View Event »

Tackling COVID-19 and its Viral Variants on the Frontline with New Vaccines and Novel Monoclonal Antibody Treatments

This COVID-19 Snapshot will explore the role of emerging SARS-CoV-2 variants and their potential impact on the efficacy of current monoclonal antibody therapies and vaccines authorized for emergency use in managing the COVID-19 pandemic.

In this module, we will discuss mutations in the spike protein of SARS-CoV-2 viral variants and the potential impact of these alterations on the efficacy of current vaccines and monoclonal antibodies authorized for emergency use management of the COVID-19 pandemic. We will also share resources and tools for the administration of monoclonal antibody infusion therapies, as well as programs and initiatives developed to improve the ease and access of diagnostic technologies across the United States.

Release Date: June 2, 2021
Expiration Date: June 2, 2022

Learn More & View Event »

A Whiteboard View of the New Era in Alopecia Areata: The Role of JAK Inhibitors

This enduring, case-based activity targets health care gaps related to the underlying autoimmune causes of alopecia areata (AA) and targeted treatment approaches, which can have a profound impact on health-related quality of life through burden of disease and associated comorbidities.

  • By addressing these gaps, you can assess whether your approach to AA management using immune-related targeted treatment approaches and comorbidity assessment could be modified to help close these gaps.
  • Expert discussion will guide you in analyzing and identifying appropriate candidates for immune-targeted treatment of alopecia with JAK inhibitors, as well as assessment and management strategies for associated comorbidities.
  • You will also be immersed in dynamic animations using a whiteboard platform to memorably highlight key points related to immune pathways in the development of alopecia areata and patient counseling techniques for tailored disease and comorbidity management.

Release Date: June 16, 2021
Expiration Date: June 16, 2022

Learn More & View Event »

COVID-19 Frontline Initiative: Supporting Patient Journeys through Resources and Tools to Promote Positive Patient Outcomes in Care

COVID-19 FRONTLINE podcasts provide a comprehensive and up-to-date perspective on the ever-changing management and prevention of COVID-19. Each podcast focuses on different issues facing clinicians and patients, such as managing patients with COVID-19, addressing the care of special populations during the pandemic, and coping with the long road to recovery.

Release Date: June 21 2021
Expiration Date: June 21, 2022

Learn More & View Event »

Seeing Clearer: Optimizing the Use of Vascular Endothelial Growth Factor Inhibitors in Retinal Vein Occlusion

This online activity targets healthcare gaps correlated with screening, multidisciplinary care and timely intervention in retinal vein occlusion (RVO), which can impact vision-related quality of life.

  • By addressing these gaps, you can assess whether your approach to RVO management through screening, utilization of clinical trial data to guide appropriate treatment and multidisciplinary coordination for comprehensive RVO management – could be modified to help both strategize treatment design and close these gaps.
  • Expert discussion will guide you in identifying appropriate opportunities for early intervention, as well as assessing impact that RVO can have on vision-related quality of life.
  • You will also be immersed in dynamic whiteboard animations to memorably highlight key points related to how the inflammatory and vascular endothelial growth factor (VEGF) pathways lead to the development of RVO, as well as the fundoscopic retinal changes associated with the various types of RVO and their subsequent consequences.

Release Date: June 30, 2021
Expiration Date: June 30, 2022

Learn More & View Event »

COVID-19 Frontline Therapies: Navigating Through This Health Crisis and Optimizing Patient Care

The COVID-19 FRONTLINE VA Grand Rounds online activity provides a comprehensive and up-to-date perspective on the ever-changing management of patients with COVID-19. The online session features in-depth case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic, and will focus on optimizing outcomes for hospitalized and non-hospitalized patients with COVID-19 through the use of novel agents authorized for emergency use.

Release Date: July 12, 2021
Expiration Date: July 12, 2022

Learn More & View Event »

Using Antiarrhythmic Drugs for the Early Management of Rhythm Control in Atrial Fibrillation: Which of Your Patients May Benefit from This Approach?

This enduring activity targets healthcare gaps related to the treatment and management of atrial fibrillation (AF), impacting outcomes through guidelines and best practices, appropriate antiarrhythmic use, and shared decision-making.

  • By addressing these gaps, you can assess whether your approach to AF management through utilization of current treatment guidelines, individualization of antiarrhythmic use and strategies for shared decision making – could be modified to help close these gaps.
  • Expert discussion will guide you in analyzing and identifying appropriate candidates for antiarrhythmic intervention, utilizing clinical trial and real-world data on efficacy, and safety to affect patient outcomes.
  • You will also be immersed in dynamic animations utilizing a whiteboard platform to memorably highlight key points related to antiarrhythmic mechanisms of action and consequences related to interactions with other cardiovascular agents.

Release Date: July 20, 2021
Expiration Date: July 20, 2022

Learn More & View Event »

Seeing Clearer: Optimizing the Use of Vascular Endothelial Growth Factor Inhibitors in Diabetic Retinopathy

This online activity targets healthcare gaps correlated with screening, multidisciplinary care and timely intervention in diabetic retinopathy (DR), which can impact vision-related quality of life.

  • By addressing these gaps, you can assess whether your approach to DR management through screening, utilization of clinical trial data to guide appropriate treatment and multidisciplinary coordination for comprehensive DR management – could be modified to help both strategize treatment design and close these gaps.
  • Expert discussion will guide you in identifying appropriate opportunities for early intervention, as well as assessing impact that DR can have on vision-related quality of life.
  • You will also be immersed in dynamic whiteboard animations to memorably highlight key points related to how the inflammatory and vascular endothelial growth factor (VEGF) pathways lead to the development of DR, as well as the fundoscopic retinal changes associated with each retinopathy stage.

Release Date: July 20, 2021
Expiration Date: July 20, 2022

Learn More & View Event »

Seeing Clearer: Optimizing the Use of VEGF Inhibitors in Age-related Macular Degeneration (AMD)

This online activity targets healthcare gaps correlated with screening, multidisciplinary care and timely intervention in age-macular degeneration (AMD), which can impact vision-related quality of life.

  • By addressing these gaps, you can assess whether your approach to AMD management through screening, utilization of clinical trial data to guide appropriate treatment and multidisciplinary coordination for comprehensive AMD management – could be modified to help both strategize treatment design and close these gaps.
  • Expert discussion will guide you in identifying appropriate opportunities for early intervention, as well as assessing impact that AMD can have on vision-related quality of life.
  • You will also be immersed in dynamic whiteboard animations to memorably highlight key points related to how the inflammatory and vascular endothelial growth factor (VEGF) pathways lead to the development of AMD, as well as the fundoscopic retinal changes associated with each stage of AMD.

Release Date: July 21, 2021
Expiration Date: July 21, 2022

Learn More & View Event »

Seeing Clearer: Optimizing the Use of Vascular Endothelial Growth Factor Inhibitors in Retinal Vein Occlusion

This online activity targets healthcare gaps correlated with screening, multidisciplinary care and timely intervention in retinal vein occlusion (RVO), which can impact vision-related quality of life.

  • By addressing these gaps, you can assess whether your approach to RVO management through screening, utilization of clinical trial data to guide appropriate treatment and multidisciplinary coordination for comprehensive RVO management – could be modified to help both strategize treatment design and close these gaps.
  • Expert discussion will guide you in identifying appropriate opportunities for early intervention, as well as assessing impact that RVO can have on vision-related quality of life.
  • You will also be immersed in dynamic whiteboard animations to memorably highlight key points related to how the inflammatory and vascular endothelial growth factor (VEGF) pathways lead to the development of RVO, as well as the fundoscopic retinal changes associated with the various types of RVO and their subsequent consequences.

Release Date: July 27, 2021
Expiration Date: July 27, 2022

Learn More & View Event »

COVID-19 Frontline Therapies: Navigating Through This Health Crisis and Optimizing Patient Care

This program provides a comprehensive and up-to-date perspective on the ever-changing management of patients with COVID-19 who present to the emergency department. The session features in-depth case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic. The case studies will focus on different issues facing clinicians, such as identifying patients who would benefit from monoclonal antibody therapy and best practices for incorporating agents authorized for emergency use into the care of hospitalized and non-hospitalized patients with COVID-19. Strategies for administering neutralizing monoclonal antibodies, such as referral to local infusion centers or developing in-clinic infusion capabilities, will also be discussed.

Release Date: August 11, 2021
Expiration Date: August 11, 2022

Learn More & View Event »

Moderate-to-Severe Atopic Dermatitis: Improving Patient Adherence to Therapy Among Veterans During the COVID-19 Pandemic

This enduring education is designed to help dermatologists, allergists, immunologists, primary care physicians, and other health care professionals in the Department of Veterans Affairs to identify the signs and symptoms of atopic dermatitis in adult patients, assess disease severity, incorporate updated guidance on the use of systemic therapy for atopic dermatitis during the COVID-19 pandemic into clinical practice, and utilize shared decision making to help individualize care.

Release Date: August 26, 2021
Expiration Date: August 26, 2022

Learn More & View Event »

Seeing Past the Treatment Horizon: Anti-VEGF Therapies and Beyond in Retinal Disease (Diabetic Retinopathy)

This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of diabetic retinopathy (DR), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.

Release Date: September 17, 2021
Expiration Date: September 17, 2022

Learn More & View Event »

Seeing Past the Treatment Horizon: Anti-VEGF Therapies and Beyond in Retinal Disease (Optometry)

This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of diabetic retinopathy (DR), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.

Release Date: September 17, 2021
Expiration Date: September 17, 2022

Learn More & View Event »

The Virtual Reality Room Seeing Past the Treatment Horizon: Anti-VEGF Therapies and Beyond in Retinal Disease Track: Age-related Macular Degeneration (Optometry)

This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of age-related macular degeneration (AMD), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
RELEASE DATE: October 01, 2021

EXPIRATION DATE: October 01, 2022

Learn More & View Event »

The Virtual Reality Room Seeing Past the Treatment Horizon: Anti-VEGF Therapies and Beyond in Retinal Disease Track: Age-related Macular Degeneration (Retina)

This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of age-related macular degeneration (AMD), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
RELEASE DATE: October 01, 2021

EXPIRATION DATE: October 01, 2022

Learn More & View Event »

Seeing New Possibilities in Retinal Disease: Anti-VEGF Therapies and Beyond

This online activity targets healthcare gaps related to the recognition, prevention, and management of diabetic retinopathy (DR). An expert panel discussion will guide you in identifying candidates for anti-VEGF therapy, review clinical trial data on the use of these agents, and provide evidence-based strategies to individualize the management of DR and overcome treatment barriers.

RELEASE DATE: October 01, 2021

EXPIRATION DATE: October 01, 2022

Learn More & View Event »

Maximizing Personalized Approaches Through Composite Biomarkers in Metastatic NSCLC: An Innovative 2D View

This activity consists of presentations from expert faculty and 2D animation technology to explain immune dysfunction and the pathogenesis of non-small cell lung cancer (NSCLC), currently available and emerging immuno-oncology used alone and in combination with chemotherapy for NSCLC, and the usefulness and application of biomarkers to guide treatment selection for NSCLC.
RELEASE DATE: October 06, 2021

EXPIRATION DATE: October 06, 2022

Learn More & View Event »

Personalizing Treatment for Parkinson’s Disease: What Can You Do to Manage Off Episodes in Your Patients?

This program will explore the management of “off” episodes in patients with Parkinson’s disease. Interactive case studies presented by expert faculty will evaluate pharmacologic approaches to reduce daily off time, including the efficacy and safety of on-demand therapies. Engaging whiteboard animation will review the pathophysiology of off episodes and the mechanism of action of treatment options.
RELEASE DATE: October 08, 2021

EXPIRATION DATE: October 08, 2022

Learn More & View Event »

Personalizing Treatment for Parkinson’s Disease: What Can You Do to Manage Off Episodes in Your Patients?

This program will explore the management of off episodes in patients with Parkinson’s disease. Interactive case studies presented by ex pert faculty will evaluate pharmacologic approaches to reduce daily off time, including the efficacy and safety of on-demand therapies. Engaging whiteboard animation will review the pathophysiology of off episodes and the mechanism of action of treatment options.
RELEASE DATE: October 21, 2021

EXPIRATION DATE: October 21, 2022

Learn More & View Event »

Seeing Past the Treatment Horizon: Anti-VEGF Therapies and Beyond in Retinal Disease Track: Retinal Vein Occlusion

This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of retinal vein occlusion (RVO), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
RELEASE DATE: October 29, 2021

EXPIRATION DATE: October 29, 2022

Learn More & View Event »

Seeing Past the Treatment Horizon: Anti-VEGF Therapies and Beyond in Retinal Disease Track: Retinal Vein Occlusion

This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of retinal vein occlusion (RVO), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
RELEASE DATE: October 29, 2021

EXPIRATION DATE: October 29, 2022

Learn More & View Event »

What Can You Do to Improve Clinical Outcomes for Your Patients with Viral Influenza at High-Risk for Pulmonary Complications?

This virtual satellite symposium discusses best practices for managing people with influenza who are at high risk for developing pulmonary complications. 2D animation technology is incorporated throughout the program to highlight the mechanism of action of point-of-care tests (POCTs) and antiviral treatments approved for treatment. Clinical data supporting the efficacy of antivirals and guidance on their use will also be provided.

RELEASE DATE: November 19, 2021

EXPIRATION DATE: November 19, 2022

Learn More & View Event »

Parkinson’s Disease Psychosis is Often Underdiagnosed and Undertreated: What Can You Do to Improve the Quality of Care for Your Patients?

In this virtual program, we will explore the management of Parkinson’s disease psychosis (PDP)–a condition that affects a substantial percentage of patients with Parkinson’s disease, typically in the later stages. Through this interactive program, clinicians will recognize symptoms, features, and diagnostic best practices in PDP. In addition, participants will learn about the underlying pathophysiology of PDP and treatments targeting these underlying pathways pivotal to the progression of PDP. Through an improved understanding of PDP, clinicians will gain insights and tools to better manage patients with PDP. Through interactive case studies presented by expert faculty, learners will be able to better evaluate pharmacologic approaches to PDP management and the efficacy and safety of approved therapeutic options. In addition, engaging whiteboard animations presented throughout will reinforce concepts learned in didactic portion, ensuring that participants understand the pathophysiology and mechanisms involved in pharmacologic management of PDP.

RELEASE DATE: November 26, 2021

EXPIRATION DATE: November 26, 2022

Learn More & View Event »

Atopic Dermatitis: Targeting Underlying Inflammatory Pathways with Systemic Therapy – THE THRIVE INITIATIVE

Upon the completion of this program, attendees should be able to:

  • Apply up-to-date guidance on the initiation and use of systemic immunosuppressants and immunomodulators in patients with atopic dermatitis during the COVID-19 pandemic
  • Assess the severity of atopic dermatitis and select appropriate treatment options for patients who require intensified therapy
  • Review the mechanism of action, efficacy and safety of systemic treatments for atopic dermatitis in pediatric and adult patients

RELEASE DATE: December 01, 2021

EXPIRATION DATE: December 01, 2022

Learn More & View Event »

Moderate-to-Severe Asthma: Targeting Underlying Inflammatory Processes to Improve Patient Outcomes

This enduring program consists of presentations from expert faculty and simulation challenge animations that will explain immune dysfunction and the pathogenesis of moderate-to-severe asthma, currently available and emerging targeted therapies used for asthma, and the usefulness and application of guidelines and biomarkers to guide treatment selection for this disease.

RELEASE DATE: December 07, 2021

EXPIRATION DATE: December 07, 2022

Learn More & View Event »

Leveraging Novel Treatment Options for Small-Cell Lung Cancer in the Second Line

This enduring virtual TeleECHO program will explore the management of small cell lung cancer (SCLC) in the second-line setting. A brief didactic presentation will discuss treatment options after relapse of SCLC and will assess clinical trial data regarding the efficacy and safety of second-line treatment regimens. Interactive case studies will illustrate the application of guideline recommendations for treatments approved for managing extensive-stage SCLC.

RELEASE DATE: December 07, 2021

EXPIRATION DATE: December 07, 2022

Learn More & View Event »

Parkinson’s Disease Psychosis is Often Underdiagnosed and Undertreated: What Can You Do to Improve the Quality of Care for Your Patients?

In this virtual program, we will explore the management of Parkinson’s disease psychosis (PDP)–a condition that affects a substantial percentage of patients with Parkinson’s disease, typically in the later stages. Through this interactive program, clinicians will recognize symptoms, features, and diagnostic best practices in PDP. In addition, participants will learn about the underlying pathophysiology of PDP and treatments targeting these underlying pathways pivotal to the progression of PDP. Through an improved understanding of PDP, clinicians will gain insights and tools to better manage patients with PDP. Through interactive case studies presented by expert faculty, learners will be able to better evaluate pharmacologic approaches to PDP management and the efficacy and safety of approved therapeutic options. In addition, engaging whiteboard animations presented throughout will reinforce concepts learned in didactic portion, ensuring that participants understand the pathophysiology and mechanisms involved in pharmacologic management of PDP.

RELEASE DATE: December 21, 2021

EXPIRATION DATE: December 21, 2022

Learn More & View Event »

Advances in the Therapeutic Management of Patients with Chronic Hematological Conditions – A Whiteboard Preceptorship

Recent advances in treatment strategies promise to improve the lives of patients with sickle cell disease or hemophilia. In this program, experts in both fields will assist clinicians in developing individualized management plans using state-of-the-art and emerging therapies, and highlight opportunities to implement multidisciplinary, patient-centered approaches to care. Case studies and interactive question and answers will provide learners practice in applying patient-specific factors to treatment decisions. This activity will feature whiteboard animations that will reinforce learning and help participants gain a higher level of understanding.

RELEASE DATE: December 21, 2021

EXPIRATION DATE: December 21, 2022

Learn More & View Event »

Understanding Cervical Biology and Oncogenesis: Leveraging Checkpoint Inhibition in Recurrent and Metastatic Disease

This case-based online activity will help gynecologists and medical oncologists improve the timeliness of screening for women at risk for cervical cancer and the accuracy of diagnosis; and recognize the limitations of currently available regimens for recurrent and metastatic disease. The education will also seek to expand awareness of the integral role that the immune system plays in the pathology of cervical cancer and how IO agents in late-stage development for patients with recurrent or metastatic cervical cancer potentially could be integrated into practice once available.

RELEASE DATE: December 23, 2021

EXPIRATION DATE: December 23, 2022

Learn More & View Event »

A Holistic Approach to Diabetes Care: Reducing HbA1c and Weight with Emerging Pharmacotherapies

  • Select therapies for the improvement of glycemic and extra-glycemic outcomes in patients with T2DM.
  • Determine the rationale for targeting GIP and GLP-1 receptors in the treatment of type2 diabetes and its metabolic comorbidities.
  • Identify patients in their own practice who may potentially benefit from treatments targeting GIP and GLP-1 receptors in the future based on knowledge of recent clinical data

RELEASE DATE: December 28, 2021

EXPIRATION DATE: December 28, 2022

Learn More & View Event »

A Holistic Approach to Diabetes Care: Reducing HbA1c and Weight with Emerging Pharmacotherapies

This activity will explore strategies to improve glycemic and metabolic outcomes in patients with type 2 diabetes mellitus (T2DM). A review of clinical trial data will enable clinicians to personalize the selection of therapies for patients and examine the role of emerging dual GIP and GLP-1 receptor agonists in the management of type 2 diabetes and obesity.

RELEASE DATE: December 29, 2021

EXPIRATION DATE: December 29, 2022

Learn More & View Event »

Clinical Conversations Exchange: A Cardiologist-PCP Collaboration Discussing GLP-1 Receptor Agonists for Reducing Cardiovascular Risk in Patients with Diabetes

  • Determine the clinical implications of results from Cardiovascular Outcomes Trials of GLP-1 receptor agonists
  • Identify patients with type 2 diabetes who are most likely to benefit from the use of GLP-1 receptor agonists
  • Personalize the selection of GLP-1 receptor agonists based on indications, guidelines recommendations and clinical data
  • Develop strategies for increasing collaboration between cardiologists and PCPs in managing cardiovascular risk in patients with T2DM

RELEASE DATE: January 27, 2022

EXPIRATION DATE: January 27, 2023

Learn More & View Event »

Advances in the Management of Prurigo Nodularis: Stopping the Itch-Scratch Cycle

  • Develop treatment regimens that address the immunological and neural components of prurigo nodularis (PN)
  • Integrate patient-specific factors, such as quality of life and comorbidities, into the selection of treatment options for the management of PN
  • Assess clinical trial data on the efficacy and safety of emerging therapies for the treatment of PN

RELEASE DATE: January 31, 2022

EXPIRATION DATE: January 31, 2023

Learn More & View Event »

Going Beyond the Classic Management of Cutaneous Squamous Cell Carcinoma: Anti-PD1 Therapy

  • Discuss the elements of immune dysfunction that drive the tumorigenesis of cutaneous squamous cell carcinoma (cSCC)
  • Review risk stratification of patients with cutaneous squamous cell carcinoma to determine who are at high risk of recurrence
  • Describe the application of medical practice guidelines and supporting trial data to the treatment of patients with locally advanced and metastatic cSCC

RELEASE DATE: February 10, 2022

EXPIRATION DATE: February 10, 2023

Learn More & View Event »

Prurigo Nodularis: Therapeutic Possibilities

  • Develop treatment regimens that address the immunological and neural components of prurigo nodularis (PN)
  • Integrate patient-specific factors, such as quality of life and comorbidities, into the selection of treatment options for the management of PN
  • Assess clinical trial data on the efficacy and safety of emerging therapies for the treatment of PN

RELEASE DATE: February 16, 2022

EXPIRATION DATE: February 16, 2023

Learn More & View Event »

New Optimal Low-density Lipoprotein Cholesterol Reductions in Patients with Atherosclerotic Cardiovascular Disease: Maximizing Clinical Benefit within the Department of Veterans Affairs

This activity is designed to help lipidologists, cardiologists, and other healthcare professionals involved in the management of US veterans with familial hypercholesterolemia (FH) to improve cholesterol and cardiovascular outcomes for veteran patients.

RELEASE DATE: February 23, 2022

EXPIRATION DATE: February 23, 2023

Learn More & View Event »

Assessing Severity of Alopecia Areata and Understanding the Role of Novel Systemic Therapies

This activity provides a practice-based learning experience for dermatologist and primary care physicians regarding the assessment and treatment of alopecia areata (AA). By participating in this Simulation Center, learners will observe an interaction between a physician and their patient with AA and will test their knowledge of diagnosis and management at key decision points along the way. The burden of AA and its associated comorbidities will be highlighted, and you will learn strategies to effectively address the psychosocial impacts of this disease with your patients.

RELEASE DATE: February 23, 2022

EXPIRATION DATE: February 23, 2023

Learn More & View Event »

Assessing the Growing Evidence in Alopecia Areata: The Role of JAK Inhibitors

This enduring activity discusses the underlying autoimmune causes of alopecia areata (AA) and the rationale of targeted treatment approaches. The burden of AA and its associated comorbidities will also be presented, and you will hear strategies to effectively address the psychosocial impacts of this disease with your patients. Features of this program include whiteboard animations and case studies.

RELEASE DATE: February 25, 2022

EXPIRATION DATE: February 25, 2023

Learn More & View Event »

Improving SMBG Skills – The Power is in Their Hands: The Role of Diabetes Self-Management Education and Support in Patients Receiving Insulin

This activity will help participants to overcome clinical inertia and other potential barriers to timely and appropriate insulin therapy in patients with type 2 diabetes. Participants will be equipped with an enhanced ability to select, titrate and adjust basal insulin regimens, and to successfully educate and empower their patients to self-manage their diabetes.

RELEASE DATE: February 25, 2022

EXPIRATION DATE: February 25, 2023

Learn More & View Event »

Managing the Older Adult with T2DM: The Role of Fixed-Ratio GLP-1 Receptor Agonist/Insulin Combinations

This CME activity will help participants identify the characteristics of older adults with type 2 diabetes that require special consideration, assess older patients with type 2 diabetes, and develop personalized pharmacotherapeutic strategies for older patients with type 2 diabetes, both in the community and in long-term care, that include the use of fixed-ratio GLP-1 receptor agonist/insulin combinations. The activity features a Situation Room, a unique online program which employs a patient simulation platform. The situation room provides interactive quizzing, testing, and training via immersion-focused 3D simulations of scenarios encountered by clinicians who care for older adults with type 2 diabetes. The experience will be customized based on who is using the simulation. One track will be aimed at geriatricians and endocrinologists, and the other will be aimed at PCPs, physician extenders and consultant pharmacists. A slide presentation will guide the learners in their selection of treatment strategies.

RELEASE DATE: February 25, 2022

EXPIRATION DATE: February 25, 2023

Learn More & View Event »

New Treatments Bring New Challenges: Can You Identify and Mitigate Therapy-related Adverse Events Associated with the Use of Immuno-oncology/Tyrosine Kinase Inhibitor Combination Therapies?

  • Interpret data from studies exploring the safety/toxicity profiles of IO/TKI combination therapies used to treat patients with advanced solid tumors
  • Develop strategies to manage the irAEs and trAEs associated IO/TKI combination therapies used for the treatment of patients with advanced solid tumors
  • Support multidisciplinary team approaches for the diagnosis and management of irAEs in patients with advanced solid tumors treated with combination IO/TKI therapies

RELEASE DATE: February 28, 2022

EXPIRATION DATE: February 28, 2023

Learn More & View Event »

Assessing the Growing Evidence in Alopecia Areata: The Role of JAK Inhibitors

This enduring activity will discuss the causes of alopecia areata and how to best manage this disease. Expert faculty will highlight the burden of alopecia areata and will offer participants strategies for implementing treatment plans that will not only address the disease itself, but also the overall health challenges for this patient population.

RELEASE DATE: March 02, 2022

EXPIRATION DATE: March 02, 2023

Learn More & View Event »

The CATALYST Initiative: Expanding Knowledge to Improve Clinical Decision-Making and Health Outcomes for Patients with Hematologic Malignancies: A Focus on CLL

This case-based enduring activity is designed to help community oncologists and the multidisciplinary care team choose the optimal treatment for chronic lymphocytic leukemia (CLL) based on patient and disease characteristics, including performance status, organ function, comorbidities, drug interactions, and genetic and molecular biomarkers; monitor for and manage adverse events; and implement SDM into clinical practice to improve patient care and QoL.

RELEASE DATE: March 04, 2022

EXPIRATION DATE: March 04, 2023

Learn More & View Event »

Immuno-oncology Therapies for the Treatment of Advanced Endometrial Cancer: Which of Your Patients May Benefit from Their Use?

This enduring TeleECHO program will explore the management of patients with advanced endometrial cancer through interactive case studies. Faculty will review strategies on personalizing the selection of treatment options based on molecular testing and discuss the management of adverse events with immune-oncology/tyrosine kinase inhibitor combination therapies.

RELEASE DATE: March 04, 2022

EXPIRATION DATE: March 04, 2023

Learn More & View Event »

Assessing the Growing Evidence in Alopecia Areata:
The Role of JAK Inhibitors

This enduring activity discusses the underlying autoimmune causes of alopecia areata (AA) and the rationale of targeted treatment approaches. The burden of AA and its associated comorbidities will also be presented, and you will hear strategies to effectively address the psychosocial impacts of this disease with your patients. Features of this program include whiteboard animations, case presentations, and a pre-recorded Q&A session.

RELEASE DATE: March 09, 2022

EXPIRATION DATE: March 09, 2023

Learn More & View Event »

Atopic Dermatitis: Managing the Burden of Moderate-to-Severe Disease and Its Associated Comorbidities

This activity will explore the management of pediatric and adult patients with moderate-to-severe atopic dermatitis through interactive case-based simulations. Expert faculty will review strategies on how to personalize the selection of systemic treatment options based on guideline recommendations, evidence-based best practice, and emerging clinical trial data. Case-based simulations will help learners identify candidates for systemic therapy and address safety and quality of life issues.

RELEASE DATE: March 11, 2022

EXPIRATION DATE: March 11, 2023

Learn More & View Event »

Exploring Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): Diagnostic Best Practices and Considerations in Addressing Underlying Inflammation

This enduring program is designed for allergists, otolaryngologists, primary care clinicians, and other clinical team members who manage chronic rhinosinusitis with nasal polyps. In this program, we will aim to discuss the burden and pathophysiology of CRSwNP, review guidelines for diagnosis and short- and long-term management, look at clinical data and biomarkers on current and novel anti-inflammatory biologics, and teach clinicians how to apply best practices for the interdisciplinary development of individualized treatment plans for these patients. We will use a combination of didactic lecture, video animations, and patient cases to effectively teach clinicians who manage this condition.

RELEASE DATE: March 11, 2022

EXPIRATION DATE: March 11, 2023

Learn More & View Event »

Optimizing the Care of Patients with Moderate-to-Severe Asthma: Minimizing Asthma Exacerbations with Biologic Therapy

This enduring program consists of presentations from expert faculty and simulation challenge animations that will explain immune dysfunction and the pathogenesis of moderate-to-severe asthma, currently available and emerging targeted therapies used for asthma, and the usefulness and application of guidelines and biomarkers to guide treatment selection for this disease.

RELEASE DATE: March 11, 2022

EXPIRATION DATE: March 11, 2023

Learn More & View Event »

Expert Perspectives on Managing Moderate-to-Severe Atopic Dermatitis in Pediatric and Adult Patients

This enduring virtual activity targets healthcare gaps related to the diagnosis, treatment, and individualized management of AD, impacting outcomes through identifying burdens affecting quality of life, assessing disease severity when considering topical vs systemic intervention, and utilizing strategies in shared decision-making when determining guideline-based care.

RELEASE DATE: March 28, 2022

EXPIRATION DATE: March 28, 2023

Learn More & View Event »

Evaluating and Managing Ocular Toxicities and Other Potential Adverse Events in the Management of Relapsed/Refractory Multiple Myeloma

This enduring TeleECHO program will explore the management of ocular toxicities and other adverse events related to treatment of relapsed and refractory multiple myeloma (RRMM). A brief didactic presentation will discuss how and why these adverse events occur. The importance of Risk Evaluation and Mitigation Strategy (REMS) programs for monitoring your patients for corneal changes and other effects of later-line therapy for multiple myeloma will also be presented. Interactive case studies will illustrate strategies for choosing therapy and for managing treatment-related adverse events in the RRMM setting.

RELEASE DATE: March 28, 2022

EXPIRATION DATE: March 28, 2023

Learn More & View Event »

Advances in the Treatment of Patients with Systemic Lupus Erythematosus: Leveraging its Pathogenic Pathways to Improve Outcomes

  • Describe the immune cells and proinflammatory proteins that represent therapeutic targets in SLE including BAFF, type 1 interferon, and cytokines associated with JAK/STAT signaling
  • Explain how dysregulated innate and adaptive immune responses lead to specific clinical manifestations and disease consequences in patients with SLE
  • Evaluate the safety and efficacy of new and emerging SLE therapies that target its pathogenetic pathways
  • Select treatments for patients with SLE based on their pathogenic rationale

RELEASE DATE: March 30, 2022
EXPIRATION DATE: March 30, 2023

Learn More & View Event »

Putting Novel Antibody Therapies for COVID-19 in Clinical Context: Evaluating Clinical Data, Monitoring, Infusion Best Practices, and Pediatric EUAs

COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.

RELEASE DATE: March 30, 2022

EXPIRATION DATE: March 30, 2023

Learn More & View Event »

Opportunities for Nephrology Fellows to Innovate on CKD risk in Patients With T2D: Novel Developments in Mineralocorticoid Antagonists

The online activity will address renoprotective therapies in care of patients with T2D and CKD with a focus on mineralocorticoid receptor antagonists and SGLT2 inhibitors. Discussion will include mechanisms of action, emerging clinical data, best practices in screening patients, and management considerations for hyperkalemia.

RELEASE DATE: March 30, 2022

EXPIRATION DATE: March 30, 2023

Learn More & View Event »

Disease Modification in Individuals with Moderate-to-Severe Rheumatoid Arthritis: Optimizing Treatment Through the Finely Tuned Selectivity for JAKs

This enduring TeleECHO activity will explore the use of JAK inhibitors for the management of rheumatoid arthritis (RA) through interactive case studies. Faculty will review emerging efficacy and safety data, discuss guideline recommended care of RA, and help clinicians identify candidates for treatment with JAK inhibitors.

RELEASE DATE: April 04, 2022
EXPIRATION DATE: April 04, 2023

Learn More & View Event »

Therapeutic Options in Hepatorenal Syndrome with Acute Kidney Injury: Confirming the Value of Systemic Vasoconstriction

This enduring activity targets healthcare gaps related to the diagnosis, treatment, and individualized management of hepatorenal syndrome with acute kidney injury (HRS-AKI), impacting outcomes through diagnosis and differentiation from other forms of AKI as well as individualizing pharmacotherapeutic management.

  • By addressing these gaps, you can assess whether your approach to HRS-AKI diagnosis and management through utilization of the latest clinical trial data on emerging pharmacotherapies – could be modified to help close these gaps.
  • Expert discussion will guide you in analyzing and identifying challenges to HRS-AKI diagnosis and staging, the evolution of pharmacotherapies in HRS-AKI, and relevant clinical considerations to their application in case management.
  • You will also be immersed in interactive, animated simulation case studies to memorably highlight key points related to assessment and treatment options in HRS-AKI.

RELEASE DATE: April 05, 2022
EXPIRATION DATE: April 05, 2023

Learn More & View Event »

Putting Novel Antibody Therapies for COVID-19 in Clinical Context: Evaluating Clinical Data, Monitoring, Infusion Best Practices, and Pediatric EUAs

This educational activity will explore the use of monoclonal antibodies for the treatment and prevention of COVID-19 in pediatric patients. A review of available clinical data will help clinicians identify candidates for therapy and select appropriate treatments based on the most up-to-date information.

RELEASE DATE: April 08, 2022
EXPIRATION DATE: April 08, 2023

Learn More & View Event »

Putting Novel Antibody Therapies for COVID-19 in Clinical Context: Evaluating Clinical Data, Monitoring, Infusion Best Practices, and Pediatric EUAs
When Should You Use Monoclonal Antibodies in Pediatric Patients?

COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.

In this episode, a pediatric infectious disease specialist will clarify when to use monoclonal antibodies in pediatric patients with COVID-19 and discuss ways to overcome challenges in administering therapy.

RELEASE DATE: April 11, 2022
EXPIRATION DATE: April 11, 2023

Learn More & View Event »

New Strategies for Reducing Cardiovascular Risk in CKD with T2D: Development of Finer Mineralocorticoid Antagonists

In this comprehensive and interactive CME activity, we will be presenting important topics in the area of diabetic kidney disease. The program includes slide-based material interspersed with interactive questions and case studies to enhance learning. The focus is on kidney disease in the diabetic patient, specifically mechanisms of disease, diagnosis and evaluation, and therapeutic options.


RELEASE DATE: April 13, 2022
EXPIRATION DATE: April 13, 2023

Learn More & View Event »

Moderate-to-Severe Atopic Dermatitis: Addressing Healthcare Disparities in Urban Communities

This enduring virtual activity targets healthcare gaps related to the treatment and management of AD in urban communities, impacting outcomes through identifying determinants that impact health in urban communities, implementing strategies in disease severity assessment across varying skin tones, and guideline-based care.

RELEASE DATE: April 13, 2022
EXPIRATION DATE: April 13, 2023

Learn More & View Event »

Worldwide Strategies for the Management of BCC and cSCC: Can Immunotherapies Provide Effective Treatment for Your Patients with Non-Melanoma Skin Cancers?

This interactive global educational activity is designed to help oncologists, pathologists, surgeons, dermatologists, and other healthcare practitioners who care for patients with advanced or metastatic basal cell carcinoma (BCC) or cutaneous squamous cell carcinoma (cSCC) to improve their knowledge of the disease, best practices for treatment, and the role of immunotherapy in managing non-melanoma skin cancer (NMSC).

RELEASE DATE: April 18, 2022
EXPIRATION DATE: April 18, 2023

Learn More & View Event »

Clinical and Managed Care Considerations in Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): Considerations in Addressing Underlying Inflammation

In this program; we will aim to discuss the cost burden and pathophysiology of CRSwNP, review guidelines for diagnosis and short- and long-term management, look at clinical data and biomarkers on current and novel anti-inflammatory biologics, and teach pharmacists how to apply best practices within the framework of interdisciplinary managed care of these patients. We will use a combination of didactic lecture, video animations, and patient cases to effectively teach pharmacists who see this condition.

RELEASE DATE: April 18, 2022
EXPIRATION DATE: April 18, 2023

Learn More & View Event »

Evaluating Treatment Selections for Chronic Spontaneous Urticaria: Managed Care Considerations

This enduring MedGames is an interactive gamification-style CME activity that covers important topics in chronic spontaneous urticaria (CSU). The educational format of this program is engaging and covers the economic and physiological burden of CSU, diagnostic algorithms, guideline recommended step-care management, and efficacy and safety of current and emerging biologic therapy.

RELEASE DATE: April 20, 2022
EXPIRATION DATE: April 20, 2023

Learn More & View Event »

Project ECHO: HR+/HER2- Metastatic Breast Cancer: What Can You Do to Optimize Patient Access to Cyclin-dependent Kinase 4 and 6 Inhibitors? – An Innovative View

This enduring TeleECHO educational series targets healthcare gaps related to the familiarity and understanding of CDK4/6 inhibitor clinical trial designs and results on efficacy, safety, and real-world studies, impacting outcomes through current practice patterns and treatment strategies in the management of HR+/HER2- metastatic breast cancer (mBC).

RELEASE DATE: May 04, 2022
EXPIRATION DATE: May 04, 2023

Learn More & View Event »

The Challenges Presented by Hypertrophic Cardiomyopathy in Clinical Practice: How Does Your Approach Compare with the Experts’?

This interactive online activity will explore the diagnosis and management of hypertrophic cardiomyopathy (HCM). A didactic presentation by expert faculty will review guideline recommendations and risk factors for complications, discuss pharmacologic and surgical treatment options, and examine clinical trial data on emerging agents. An animated case will allow learners to apply what they have learned in a simulated clinical encounter.

RELEASE DATE: April 28, 2022
EXPIRATION DATE: April 28, 2023

Learn More & View Event »

Putting Novel Antibody Therapies for COVID-19 in Clinical Context: Evaluating Clinical Data, Monitoring, Infusion Best Practices, and Pediatric EUAs

COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.

In this episode, an emergency medicine physician will discuss strategies for the administration of monoclonal antibodies in adult and pediatric patients in an emergency department setting.

RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023

Learn More & View Event »

A Nurses’ Perspective: Oral Therapies in Breast Cancer: Considerations for Enhanced Adherence in the Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2-negative Breast Cancer

Oncology nurses are in an inherently valuable position to be in the frontline of breast cancer treatment for patients. Given identified gaps and faculty feedback, the instructional design of this program is a multi-pronged educational approach designed for an oncology nursing audience. 

RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023

Learn More & View Event »

Psoriatic Arthritis Management: Application of Guidelines and Clinical Evidence for Better Results and Safety

This educational activity will assess the pathophysiology and disease domains of psoriatic arthritis as well as review FDA-approved agents and their roles in in treating the disease. Additionally, we will discuss the appropriateness of combination or monotherapy regimens and unanswered questions in this area.

RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023

Learn More & View Event »

Incorporating Clinical Trials Data into the Management of DR, AMD, RVO, mCNV, and PCV

This enduring activity targets healthcare gaps related to the early intervention of retinal vascular diseases and familiarity with new and emerging clinical trial data, impacting outcomes through assessment and synthesis of clinical trial structures, and outcomes of studied anti-VEGF agents for incorporation into treatment strategy development.

RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023

Learn More & View Event »

The RELIEF Initiative: Reducing the Burden of Axial Spondyloarthritis Through Screening and Referral

This live virtual activity will help clinicians reduce the significant delay between onset of symptoms and diagnosis of axial spondyloarthritis (axSpA) by identifying patients with inflammatory back pain who should be promptly referred to a rheumatologist for further assessment. Case studies and engaging whiteboard animations on the features of axSpA and the consequences of delays in diagnosis create a memorable and practical learning experience.

RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023

Learn More & View Event »

The RELIEF Initiative: Reducing the Burden of Axial Spondyloarthritis Through Screening and Referral

This enduring activity will help clinicians reduce the significant delay between onset of symptoms and diagnosis of axial spondyloarthritis (axSpA) by identifying patients with inflammatory back pain who should be promptly referred to a rheumatologist for further assessment. Case studies and engaging whiteboard animations on the features of axSpA and the consequences of delays in diagnosis create a memorable and practical learning experience.

RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023

Learn More & View Event »

Checkpoint Inhibitors for Advanced Non-small Cell Lung Cancer: Understanding Current First-line Strategies

This activity provides a practice-based learning experience for medical oncologists, pulmonologists, nurse practitioners, and other health care providers, regarding the assessment and treatment of non-small cell lung cancer (NSCLC) in the first-line setting. By participating in this Simulation Center, learners will observe an interaction between a patient with NSCLC and their healthcare provider, and will test their knowledge of diagnosis and management at key decision points along the way.

RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023

Learn More & View Event »

Clearing the Air on Modern Pneumococcal Vaccination Strategies: Improving Population Outcomes and Simplifying Complex Recommendations in Managed Care

Pneumococcal disease caused by Streptococcus pneumoniae is the leading cause of pneumonia-related deaths and poses an important global public health concern. There are several vaccines available for prevention of this disease, but their implementation in the clinic is challenged by complex recommendations of their administration for various patient populations and by complicated guidelines for appropriate spacing and sequencing of vaccine schedules. Managed Care Specialists need to understand the nuances of pneumococcal vaccines to guide physicians on their appropriate use to reduce infections and improve clinical outcomes, particularly for at-risk patients. This educational activity will explore the impact of pneumococcal disease, pathophysiology of disease, guidelines recommendations, and strategies for managing vaccine hesitancy. In addition to a didactic presentation, the program features animations and case discussions to highlight the different aspects of this disease.

RELEASE DATE: May 10, 2022
EXPIRATION DATE: May 10, 2023

Learn More & View Event »

Novel Mechanisms and Emerging Agents for Anemia of CKD: Best Practices for Evidence-Based Care Across Specialties

This online activity with an integrated case-based learning component will enable clinicians to recognize emerging targets in the management of anemia of chronic kidney disease (CKD) through an understanding of the underlying pathophysiology and clinical trials evaluating novel therapies. By integrating these data with the current standards of care in the management of anemia of CKD, clinicians will be better able to understand the role of multiple healthcare professionals in the management of this common complication of CKD. Additionally, the integrated case-based activity within this program will ensure that healthcare professionals can readily translate learnings to patient interactions, ensuring that patients and the healthcare team are aware fully aware of emerging therapeutic alternatives.

RELEASE DATE: May 13, 2022
EXPIRATION DATE: May 13, 2023

Learn More & View Event »

Preventing Structural Damage in Psoriatic Arthritis: A New Domain

Through a series of informative lectures and podcast interviews, this educational series will target clinicians in the field of rheumatology who have patients with psoriatic arthritis. We will provide the latest information on clinical presentation, differential diagnosis, therapeutic targets, and clinical trial data on current and emerging therapies to help learners reduce both short- and long-term consequences of the disease.

RELEASE DATE: May 13, 2022
EXPIRATION DATE: May 13, 2023

Learn More & View Event »
Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.